
Join to view full profile
800 E Dawson StTyler, TX 75701
Phone+1 903-510-1186
Fax+1 903-531-5097
Dr. Zhang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonResidency, Gastroenterology, 2016 - 2022
UPMC Medical EducationFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
Westchester Medical CenterResidency, Internal Medicine, 1999 - 2002
Beijing Medical UniversityClass of 1987
Certifications & Licensure
MD State Medical License 2026 - 2027
TX State Medical License 2005 - 2027
IL State Medical License 2022 - 2026
LA State Medical License 2020 - 2026
WY State Medical License 2024 - 2026
MN State Medical License 2024 - 2025
TN State Medical License 2022 - 2025
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2013, 2016
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2013, 2016
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
Publications & Presentations
PubMed
- 24 citationsPyroptosis correlates with tumor immunity and prognosis.Xiaoying Lou, Kexin Li, Benheng Qian, Yiling Li, Donghong Zhang
Communications Biology. 2022-09-06 - 18 citationsReducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.Jiongyu Chen, Yixuan Zhuang, Ping Wang, Jinfeng Ning, Wei Liu
Cell Death & Disease. 2022-03-07 - 28 citationsYTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-MutationXiaoying Lou, Jinfeng Ning, Wei Liu, Kexin Li, Benheng Qian
Cells. 2021-07-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:













